The role of capecitabine as maintenance therapy in de novo metastatic nasopharyngeal carcinoma: A propensity score matching study.

Xue-Song SunSai-Lan LiuYu-Jing LiangQiu-Yan ChenXiao-Yun LiLin-Quan TangHai-Qiang Mai

Published in: Cancer communications (London, England) (2020)

Capecitabine maintenance therapy may be superior to non-maintenance therapy in prolonging OS for de novo metastatic NPC patients with pretreatment EBV DNA ≤ 30,000 copies/mL.

Keyphrases

squamous cell carcinoma
small cell lung cancer
clinical trial
epstein barr virus
phase ii study
metastatic breast cancer
mesenchymal stem cells
cell free
circulating tumor cells